If you could prevent a health problem, would you?

You exercise, you try to eat healthy, maybe you watch your cholesterol or blood pressure, but what about the things outside your control — like an unexpected fall? What if you could help prevent that? You can. 

Introducing: Rover — the first clinical, at-home tool to analyze your gait and give you a full fall risk report sent right to your mobile phone. Rover is a high-precision gait analysis device that analyzes 24 different gait parameters to show if you’re at risk of falling and what you can do to prevent it.


How it works:

Rover uses advanced, clinical-grade motion sensing and gait analysis algorithms tested at Stanford University, the Parkinson’s Institute, and University of Calgary. Developed in collaboration between human motion analysis scientists, physical therapists, neurologists, and neuroscientists over the span of five years, Rover is the first of its kind to seamlessly bring medical-grade gait analysis into the home.

 

Executive Team


 

Dr. Hamid Najafi, Ph.D

Co-Founder, CEO & CTO, Board Member

Hamid is the CEO of Rover Health, co-founded in 2012. Prior to Rover, he was the General Manager of Invensense International and Senior Director of Applications Engineering at Invensense, a leading Silicon Valley manufacturer of MEMS motion sensors.

He co-founded Broadlink Research in 2005, where he developed the first mobile phone for Disney, which was marketed by Vodafone in Europe.  He invented the first fully integrated cellular signal repeater for consumer applications. Hamid founded Wireless Link, a developer of advanced wireless products, which was sold in 2000 to CSI Wireless in Canada, where he then served as CTO for three years.

Hamid has fourteen patents and five more pending. He has a Ph.D. in electrical engineering from Stanford University.


Gabriel Griego

VP Sales and Marketing

Gabriel is a seasoned sales and marketing leader, with a track record of building memorable brands in both consumer and medical markets. Gabriel has been successful in a variety of industries and products from start-up to mid-sized companies. At PowerBar he was part of building a world class brand and new category of product that resulted in a highly successful sale to Nestle. At Game Ready, Gabriel created and launched a new product that became one of the most recognized brands in the physical therapy and orthopedic industries. Gabriel later joined AlterG and led the launch of the company’s new product focused on physical therapy, resulting in volume tripling and AlterG becoming a category and industry leader.


Adi Iyer, M.D.

Chief Medical Officer

Adi is a fellow in endovascular neurosurgery at Stanford University and an established medical researcher with 35+ peer-reviewed publications. He is a member of the American Physician Scientists Association, American Association of Neurological Surgeons, and Congress of Neurological Surgeons, and has a medical degree from the University of Pittsburgh and a master’s degree in Computational and Applied Mathematics from Cornell University.


 

Advisory Board


 

Hamid Farzaneh

Co-Founder, Chairman & Board Member, Rover Health

 

Dr. Mehrdad Shamloo, Ph.D

Associate Professor of Neurosurgery, Stanford Neurosciences Institute
Advisor, Rover Health

Hamid Farzaneh is a veteran Silicon Valley CEO passionate about building innovative high tech companies. He is a charismatic and high energy leader who believes in the business philosophy of “differentiate or die”.  He focuses on empowering teams of outstanding people and driving for time-to-market and complete customer satisfaction.

Hamid co-founded Alea Labs, Inc. in 2015 to develop and market products aiming at making the archaic HVAC industry smart, user-friendly and energy frugal. Prior to Alea, he co-founded Rover Health in 2012 to create manufacturing-ready platforms that enabled entrepreneurs to bring innovative “Wearables” products to market in record time.  Prior to Rover Health, Hamid was CEO of Optilux, of Varioptic and of DisplayLink, COO at Atheer, Motion Sense & Genesis Microchip, and EVP at Silicon Optix.

Hamid holds a Master of Science degree in Mechanical Engineering from the Institut National des Sciences Appliquées of Lyon, France and an MBA from Golden Gate university of San Francisco, CA.


Dr. Mehrdad Shamloo received his doctoral degree in 1999 from the Wallenberg Neuroscience Center of Lund University in Sweden. He was recruited to the San Francisco Bay Area the same year where he held several positions at biopharmaceutical companies, including Affymax and AGY Therapeutics, until 2008. During this time he was responsible for the discovery and development of novel neuroprotective and regenerative small molecule and peptide therapeutics for multiple diseases. As the program leader for neuroprotection and regeneration programs at AGY Therapeutics, his work enabled several patent applications, scientific publications, and an IND application and subsequent clinical trials. These years of experience in industry built on his extensive background in CNS drug discovery and preclinical development.

In 2008, Mehrdad joined Stanford University to establish a new behavioral neuropharmacology center for the neuroscience institute. He also formed his own research laboratory to focus on understanding normal and pathological brain functions for neurological disorders such as stroke, Alzheimer’s disease (AD), and autism. Efforts are currently directed towards a subset of genes and proteins involved in neuroprotective or neurodegenerative pathways, which are regulated in these disorders. Through these investigations, Mehrdad and his team hope to understand the processes leading to the functional and behavioral malfunction in these disorders and develop experimental therapeutics. The ultimate goal is to accelerate the translation of these experimental discoveries into novel therapeutic approaches, to improve the quality of life for patients with brain disorders.


Dr. Leslie Torburn, DPT

Physical Therapist, 30 years motion analysis
Advisor, Rover Health

Dr. Leslie Torburn has been a physical therapist for over 30 years. She has worked in motion analysis laboratories for most of her career, beginning as a research physical therapist working closely with Dr. Jacquelin Perry at Rancho Los Amigos National Rehabilitation Center. She has numerous publications in the areas of gait and movement analysis.

She is currently on staff at the Motion Analysis Laboratory of a major children’s hospital in northern California. Dr. Torburn received her Master of Science in Physical Therapy from the University of Southern California and her Doctor of Physical Therapy from Temple University.


Dr. Jaime Tenedorio

Medical Device Commercialization, CEO, Scanadu
Advisor & Board Member, Rover Health

Dr. Jaime Tenedorio has been an executive and co-founder at a number of start-ups in the health and medical arenas and been a key participant in many mergers, acquisitions and fund raising activities for a broad variety of companies. He has served as a CTO, COO and VP level executive at a number of Silicon Valley companies where he was responsible for defining and implementing technology strategy, product direction and development of products for the Wireless Communications, Medical and Consumer Electronics markets.

Jaime is currently the CEO of Scanadu which makes medical technology devices for consumers, combining a broad array of technologies and sensors with intelligent algorithms to create FDA cleared products.

Jaime earned his Bachelors, Masters and PhD degrees in Electrical Engineering at Cornell University. He serves on the boards of two Silicon Valley companies in the technology and medical arenas.


Michael Minkevich

Advisor & Board Member, Rover Health

Michael Minkevich is a seasoned international hi-tech executive with diverse background that covers multiple functional areas and industry verticals, including Telecommunication, Software, Automotive, Energy & Utilities, Digital Media and IoT. Throughout his career, Michael held various executive positions at the global IT/software services companies. In his most recent role at Luxoft (NYSE:LXFT) he was responsible for the company’s global product engineering organization and was instrumental in making it a recognized leader in the product development services.

Currently Michael is a venture partner at Maxfield Capital, a boutique VC fund that focuses on emerging technology companies related to IoT, artificial intelligence, telecommunications, cybersecurity and digital health. He also serves as a board member of several early stage startups.

Michael has in-depth knowledge of all aspects of system engineering and product development lifecycle as well as good understanding of the contemporary technology landscape in the context of multiple industry verticals. He is also helping enterprise customers and smaller startups with development and implementation of their outsourcing strategies. Michael holds a Master of Computer Science degree from Novosibirsk State Technical University and completed business studies at Stanford GSB and MIT.


Nicholas C Anderson

Payer Approval Specialist, Health & Medical Technology Analyst
Advisor, Rover Health

Nic is a Health Economist and Medical Technology Analyst from Salt Lake City, Utah who works full-time as a Payer determining which medical technologies are paid for. He is also a consultant to Venture Capitalists and start-ups who are working on new life science products helping them identify what health insurance companies and hospitals want in a technology and for what they’re willing to pay. Nic is also a Strategic Advisor to a number of medical technology companies. He is a guest lecturer at UCSF School of Medicine, University of Utah and at conferences and symposiums where he speaks on clinical trials, HEOR and reimbursement.